In the last decade or more, the global prevalence of depression has continued to rise[1,7], with depression accounting for approximately 12% of hospital admissions, 50% of mental health consultations, and 4% of suicides[6,8,9]
FDA Regulatory Notice: As of February 2026, the FDA has resolved the semaglutide drug shortage and has stated its intent to prioritize enforcement against certain mass-marketed non-FDA-approved GLP-1 products
In this formulation it is only ok for nursing, not pregnancy
Biopharmaceutical benchmarks 2022
Then a combination of healthy lifestyle changes (think: better sleep, less stress) alongside a balanced, nutrient-rich diet and complementary wellness therapies, such as IV Drip Therapy